Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias

Figures & data

Table 1 According to the National Institute of Health website,⁹⁶ these diseases are being studied in clinical trials currently being conducted

Diseases being considered in current clinical trials
Aphasia resulting from stroke	ADHD
Alcohol consumption	Opioid and heroine dependency
Traumatic brain injury	Multiple sclerosis
Moderate to severe AD	Compulsive buying
Frontotemporal dementia	Kleptomania
Bipolar disorder	Depressive disorder
Bipolar depression	Neurological symptoms of fragile X syndrome
Autism	Huntington’s disease
Pathological gambling	Essential tremors
General anxiety disorder	Amytrophic lateral sclerosis
Social anxiety disorder	Down’s syndrome
Shizophrenia	Tobacco abuse
Several types and subtypes of dementia	Chronic orthostatic intolerance

Table 2 According to the National Institute of Health website,⁹⁶ these diseases were studied in completed clinical trials

Diseases considered in completed clinical trials
Amyotrophic lateral sclerosis	AIDS dementia complex
Mild to moderate AD	Depression
Lupus erythematosus	Depressive disorder
Parkinson’s disease dementia	Tension-type headache
Dementia with lewy bodies	Binge-eating disorder
Parkinson’s disease	Side effects of radiation therapy for brain tumors
Co-morbid alcoholism and depression	Neuropathy secondary to herpes-zoster
Schizophrenia	Diabetic neuropathy
Obssessive-compulsive disorder	Open-angle glaucoma

ClinicalTrials.gov [homepage on the internet]MarylandUS National Library of Medicinec1993–2008 [updated 2009 June 2; cited 2009 June 15]. http://www.clinicaltrials.gov/

 Google Scholar